Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hoang Nam Vu | - |
dc.contributor.author | Kim, Ji Young | - |
dc.contributor.author | Hassan, Ahmed H. E. | - |
dc.contributor.author | Choi, Kihang | - |
dc.contributor.author | Park, Jong-Hyun | - |
dc.contributor.author | Park, Ki Duk | - |
dc.contributor.author | Lee, Jae Kyun | - |
dc.contributor.author | Pae, Ae Nim | - |
dc.contributor.author | Choo, Hyunah | - |
dc.contributor.author | Min, Sun-Joon | - |
dc.contributor.author | Cho, Yong Seo | - |
dc.date.accessioned | 2021-06-22T17:24:04Z | - |
dc.date.available | 2021-06-22T17:24:04Z | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.issn | 1464-3405 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/14626 | - |
dc.description.abstract | We described here the synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as potential mGluR5 antagonists. We found that a series of thiazole derivatives 6 showed better inhibitory activity against mGluR5. Compounds 6bc and 6bj have been identified as potent antagonists (IC50 = 274 and 159 nM) showing excellent in vitro stability profile. Molecular docking study using the crystal structure of mGluR5 revealed that our compounds 6bc and 6bj fit the allosteric binding site of mavoglurant well. (C) 2015 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Pergamon Press Ltd. | - |
dc.title | Synthesis and biological evaluation of picolinamides and thiazole-2-carboxamides as mGluR5 (metabotropic glutamate receptor 5) antagonists | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1016/j.bmcl.2015.11.012 | - |
dc.identifier.scopusid | 2-s2.0-84949500511 | - |
dc.identifier.wosid | 000366161600027 | - |
dc.identifier.bibliographicCitation | Bioorganic and Medicinal Chemistry Letters, v.26, no.1, pp 140 - 144 | - |
dc.citation.title | Bioorganic and Medicinal Chemistry Letters | - |
dc.citation.volume | 26 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 140 | - |
dc.citation.endPage | 144 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | NEGATIVE ALLOSTERIC MODULATORS | - |
dc.subject.keywordPlus | GASTROESOPHAGEAL-REFLUX DISEASE | - |
dc.subject.keywordPlus | FRAGILE-X-SYNDROME | - |
dc.subject.keywordPlus | NEUROPATHIC PAIN | - |
dc.subject.keywordPlus | PHARMACOLOGY | - |
dc.subject.keywordPlus | MGLU(5) | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | EXPOSURE | - |
dc.subject.keywordAuthor | Metabotropic glutamate receptor | - |
dc.subject.keywordAuthor | Antagonist | - |
dc.subject.keywordAuthor | Picolinamides | - |
dc.subject.keywordAuthor | Thiazole-2-carboxamides | - |
dc.subject.keywordAuthor | Molecular docking | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0960894X15302213?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.